OverviewChartNewsTraderScreen

Soc. Generale Call 320 AMGN 16.01.../  DE000SW8QVJ7  /

Frankfurt Zert./SG
2024-09-20  9:48:49 PM Chg.+0.110 Bid9:59:32 PM Ask9:59:32 PM Underlying Strike price Expiration date Option type
4.790EUR +2.35% 4.790
Bid Size: 1,000		 4.820
Ask Size: 1,000		 Amgen Inc 320.00 USD 2026-01-16 Call
GlobeNewswire 08-29 Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire 08-28 Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire 08-26 Molecular Partners Reports H1 2024 Corporate Highlights and Financials
GlobeNewswire 08-26 Eliem Therapeutics Announces Additions to its Leadership Team
GlobeNewswire 08-15 Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire 08-12 TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 08-08 CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 08-08 Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
TeleTrader 08-07 US closes lower with earnings in focus
TeleTrader 08-07 US turns red, Dow loses more than 200 pts
GlobeNewswire 08-07 89bio Appoints Francis Sarena as Chief Operating Officer
TeleTrader 08-06 Amgen books revenue of $8.4B in Q2, up 20%
TeleTrader 08-06 US extends premarket gains, Dow surges 250 pts
GlobeNewswire 08-05 Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
TeleTrader 08-01 Dow jumps 250 pts as Meta surges more than 10%
GlobeNewswire 08-01 CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024
GlobeNewswire 07-22 Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 202...
GlobeNewswire 07-09 ImCheck Appoints Stephan Braun as Chief Medical Officer
GlobeNewswire 07-02 Alvotech Announces Positive Topline Results from Confirmatory Patient Study for AVT03, a Proposed Bi...
GlobeNewswire 07-01 Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
GlobeNewswire 06-27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 06-27 Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All ...
GlobeNewswire 06-26 COUR Pharmaceuticals Appoints Tim Walbert to its Board of Directors
GlobeNewswire 06-26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer
GlobeNewswire 06-25 Arthritis Foundation Launches Carolina Hills Classic Bike Tour, Coming June 2025